> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Temporary Policy on PPE Used in Drug Compounding
- URL: https://www.fdaweb.com/temporary-policy-on-ppe-used-in-drug-compounding/
- Published: 2020-04-10T12:00:00.000Z
- Updated: 2026-09-14T16:10:51.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5146545

FDA has issued a [guidance](http://s2027422842.t.en25.com/e/er?utm%5Fcampaign=Temporary%20Policy%20Regarding%20Non-Standard%20PPE%20Practices%20for%20Sterile%20Compounding&utm%5Fmedium=email&utm%5Fsource=Eloqua&s=2027422842&lid=12618&elqTrackId=DA35FBB7808E7831CC39EBEAC28C8062&elq=e1113409b2994b5894f97eeaf9e7c97e&elqaid=12046&elqat=1) entitled “Temporary Policy Regarding Non-Standard PPE Practices for Sterile Compounding by Pharmacy Compounders Not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency.” The document discusses how pharmacies may be able to preserve personal protective equipment used in their compounding operations if supplies are limited. Further, as a temporary measure during the Covid-19 emergency, the agency is providing limited regulatory flexibility for compounders that cannot obtain sufficient supplies of PPE for sterile compounding, provided they adopt risk mitigation strategies as described in the guidance.